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Medical Device Legislation: 
Its Professional Implications -
By Reed M. Gardner, Ph .D.* 
After severa l years of consideration in Congress , medical device legis lation became law 
(PL 94-295) on May 28, 1976. Thi s law, to be administered by the Food a nd Drug 
Administration (FDA), will have a signi ficant impact on the design, manufacture , a nd 
distribution of medical equipment- its impact on the hea lth ca re provid er and the 
health care profess io nal is less apparent. However, there are s ignif ican t new responsi-
bilities, possible limitations, and, hopefully, benefits to be gained from t he new law 
by these professionals . To point up the se factors, a brief rev iew of the histmi cal back -
ground of the FDA and its regulatory authority will be useful. 
Th e early colonists, realizing the impor-
tance of having high quality food produc ts, 
set up an eva lu ation system to ensu re the 
quality of tea , w heat, etc. Regulation of 
foods and drugs was primarily a states 
rights issue until 1906, when the original 
Fede ral Food and D rug Statute was en-
acted. The primary concern of t h is law 
was to keep adulterated and mi sbranded 
drugs out of interstate commerce. The 
1906 act was weak in that it required no 
pre-market safety testing and no effective -
ness eval uation. It took the "E lix ir of 
Sulfanilamide" disaster in 1938, in w h ich 
more than 100 people died, to sti mul ate 
further legi slation. Th is disaste r, with its 
negative press coverage, resulted in Con-
gress enacting the legi slati on establ ishing 
the FDA in 1938. The resu lt w as a more 
str ingent regu lation on man ufacture of 
drugs in order to assure their safety by 
pre-market clinical trials . However , the 
1938 law required no demonstration of 
effective ness of drugs. It took the "th al -
idomide" disaster in Europe in 1962 to 
bring the public and Congress to th e deci -
sion that drugs used for investigational 
purposes needed to be pre-marke t t est ed 
for both safety and effectiveness . T hu s, 
the 1962 amendment to the 1938 law . 
Notice the reaction of Congress to each 
of these disasters. F irst, there w as a prob-
lem ; secondly, the probl em was w ide ly 
covered by the press, who cried that the 
public should be protected; then Congress 
enacted legi slation that increased FDA's 
authority t o protect the pub I ic. 
Another Call for Cong ressional Action 
The past three decades have seen a prolif -
eration of a variety of type s of med ical 
devices, so me of which have caused se rious 
injury or death to patients, and o t hers of 
which have saved lives. The medical d evice 
failures came under the scrutiny of the 
press , the pub I ic, and Congress, and, as a 
result, after several y ea rs of delibe rations 
and hearings Congress enacted the legi s-
lation wh ich has become know n as the 
Medica l Device Amendment of 1976. 
According to the law, "the term 'dev ice ' 
' Cha irman, Medi cal Devices Committ ee . 
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means an in strument , apparatus, imple-
ment, machine, contrivance, implant, in 
vitro reagent, or other similar or re lated 
article, including any component, part, or 
accessory , which is- 1) recognized in the 
official National Formu lary, or the Un it ed 
States Pharmacopeia, or any suppl ement 
to th e m; 2) intended for use in t he diag-
nosis of disease or other conditio n, or in 
the cure, mitigation, treatment, or preven-
tion of disease, in man or other animals , 
or 3) intended to effect th e structu re of 
any function of th e body of man or other 
an imal and wh ich does not achieve a ny of 
its principal intended purposes through 
chemica l action within or on th e body of 
man or other animals and which is not 
dependent upon being metabo lized for 
the achie vement of any of its principal 
purposes." Th is quotation from the legis-
lation gives an exampl e of the langu age of 
the legi s lation, which is some 45 pages 
long . The definition of a "device" has 
sign ifi cant implications . For exam pl e, 
there are some drugs w hich w il l now be-
come devices. The orde rly tran sition fro m 
drugs to devices is ou t lined in the legis la-
tion. 
Device Classifications 
A prim ary e le ment of the legis lat ion ca ll s 
for an orderly c lassification of devices . 
There are three speci f ic c lassest : Class I 
is general control. De vices in this class are 
those that are not used in supporting or 
sustai ning human life and that don 't carry 
a po tentia l unreasonabl e risk of illness or 
injury . A Class II device must m eet per-
forman ce standards w hich mu st be estab-
li shed in order to provide reasonable 
assurance of th e safety and effectiveness 
of th e device. Class Ill is pre-market 
appro val . These devices do not fit into 
either of the other cla sses and are d esi gn ed 
for use in supporting or susta ining human 
life or in preventing impairment of human 
health ; they may carry a pote nti a l unrea-
sonable risk of illness or injury . 
The c lass ification of devices wi ll be the 
job of the Secretary of Hea lth , Education 
t For a d etai led desc ription of tlw threP c losses, 
see Schmidt, A .. Med icil l device IP.gi sla tion , 
ATS New s, Summer 197 6, 2 , p . 1G. 
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and We lfare (HEW) and wi ll be d 
prim a rily by panei s w hi ch are given 
year from th e e nactrnent o f t he le gi sl a1 
to class ify all m ed ical dev ices into o nt 
the thre e classe s. Th e refo re, th e pat 
hav e con s id e rabl e sc ie nt if ic and po lit 
powe r. 
Sci e n t ific groups are given auth o r ity 
nominate membe rs to t h e pane ls . · 
American Th oracic Soc ie ty cutT 0. ntly 
Dr. Ea rle B. Wei ss se rving and w il l st 
have Dr. Philip C. Ho pewel l from ~ 
F ranci sco servin g o n th e Pulmo nary S 
committee of th e Anest hesiology Pat 
We are a lso w o rki ng t o get a sepa t 
pan el se t up for pu lmon a ry func t 
equipment. 
Unl ess othe rw ise specified, a de vice 1 
a u tomatically be class if ied Cl ass Ill .-
Sec re tary of HEW can at any ti me cha· 
a device classifica tion based o n hea r! 
or oth e r inform at io n availab le to him. 
can c lassify a d evice as Class II w hil e r 
formance stand ards , includi ng specif i 
tion s for constru ctio n, tes tin g, labe l i 
and measuring d evi ce pe dorm a nce , 
being dev e loped . 
The law require s pe riod ic eva luation < 
upd ating of device cl ass ifi ca t io ns by 
pan els . Th e FD A w ill loo k t o stan d a 
setting org anizati ons fo r upda t ing. It 1· 
be poss ib le for voluntary organ izat ic 
such as A TS to propose stand a rd s t o 
FDA. Input from volunt ary and stand a· 
organizations is provided for in th e : 
and is welco med by th e st aff of the Mt 
cal Devices Burea u of t he FDA ._ Th is [ 
reau is very interes ted in vo lu ntary co c 
erat ive standards' e st abli shing arran 
ments with any o rganiz at ion , espe cia 
professiona l grou r s. Befo re it ca n 
applied, a stand at·ci must be published 
the Federal Regi ste r. Sin ce thi s is n01 
scientific journal and d oes no t have 1 
wid e readersh ip t h at American A'eview 
Respiratory Disease d oes, th e sta ff 
ATS and th e Medi cal De vi ces Co mm it 
will t ry to kee p re ade t·s in form ed on itc 
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relating to the medical devices legislation 
through the ATS NEWS. For readers who 
have a personal interest and who are 
involved in device testing and evaluation, 
it will be necessary to personally review 
the device legislation and the appropriate 
sections of the Federal Register in order 
to understand the rulings on individual 
dev ices. 
Those scientists and investigators working 
with institutions w ould be wise to consult 
their institutional legal officers before 
getting involved in the development of a 
new "device." (.l\ppropriate publications 
and their sources are listed below). 
Those prod ucts which were manufactured 
and sold in interstate trade before May 
28, 1976 , will not be controlled under 
the device legislation for a period of at 
least t hree years. During that time period, 
pane ls will c lass ify devices and standards 
will be developed for them. The primary 
impact of the legislation, at the moment, 
is on th e manufacture r who must im-
mediately get pre- marke t a pproval before 
a new product can be te sted. Th e manu-
facture r also will be required to regis ter 
all medical devices . A product develop-
ment protocol must be out I i ned very care · 
fu lly in order for it to 1·eceive FDA 
approval. There is a chance that this 
proced ure will have a deleterious economic 
impact on the manufacturers , "but the 
Commiss io ner of the Food and Drug 
Administ ration has determined that t his 
will not likely cause a significant economic 
impact." 
Ad visory committees , rather than review 
pane ls, will re view medical devices for 
pre-market app rova l. Aithough banned 
devices may be removed from the market 
by th e HEW Secretary, there is a provi sion 
for judicia ! review of such cases . 
The HEW Secretary may issue a "recall" 
order to ass ure that adequate notif ication 
is provided in order to eliminate ri sk to 
all health professionals or lay persons 
who prescribe or use a device. Recall 
orders "shall require that the health pro-
fess ional s who prescribe or use the device, 
provide notification of the individuals 
whom th e health profess ional treated with 
the device of the risk presented by the 
device and of any action which may be 
taken by or on behalf of such an individual 
to eliminate or reduce such risk ." Details 
of the recall procedure and of repair, 
replacement , o r refund fo r defective 
dev ices arP. outlined in the legislation . 
The primary burden for reporting and 
keeping records on devices res ts on the 
'The Secretary of HEW can at any time change a device classification 
based on hearings or other information available . ... The FDA will look 
to standard-setting organizations for updating. It will be possible for vol-
untary organizations such as A TS to propose standards . .. 
" . .. . Most of the burden of the legislation, currently on the manufacturer, 
will soon shift to the professionals." 
manufacturer, not the physician . Practi-
tioners are specifically exempt from de-
tailed record keeping when the device is 
used solely in research and teaching, not 
for sale. Details of the implementation 
of record keeping will await action by the 
FDA in setting up its specific policies. 
Class I devices will be exempt from record 
keeping and reporting. 
Custom devices, particularly those in-
tended to meet the special needs of 
physicians or dentists or other specially 
qualifi ed perso ns , are specifically exc luded 
from legislative controls. Trade secrets 
are gu aranteed. 
The Secretary of HEW may by regulation 
require that a device be restricted to sale, 
distribution, or use o nly upon written or 
o ral authorization of a practitioner 
licensed by law to administer or use such 
a device, or upon such other conditions 
as the Secretary may prescribe in such 
regulation. 
All devices w ill be required to m eet good 
manufacturing pract ice standards, which 
will be es tablished by a group specified 
by the law to re present government, 
manufacturers, practitior.ers, ar.d the 
public. 
Invest igational devices are exe mpted from 
the law for the purpose of encouraging to 
the extent cons istent with the protection 
of th e publ ic health and safety, di scovery 
and development o f useful devices in-
tended for human use . The FDA has been 
give n 120 days starting from th e enact-
ment of legislation to set up th e proce-
dures and conditions . The form for this 
has bee n proposed in the August 20, 1976 
Federal Register. The primary approved 
e leme nts of investigational device experi-
mentation are ( 1) that a request will have 
to be made to the FDA for approval by 
a loca l "approved investigational commit-
tee," which can be the same committee 
as those used now for approving human 
subjects related research for NIH ; (2) that 
a request must then be sent to the FDA 
outlining the research plan; and (3 ) that 
within 30 days after the FDA has received 
the request, if it is not denied, it is auto-
matically approved for investigational use. 
In gen e ral, animal testing will not require 
FDA approval, and in many cases it will 
be valuable to do before submitting a 
request for approval. 
The HEW Secretary is required to release 
safety and effectiveness information on 
devices in order to keep the public 
properly informed. The safety of a device 
cannot be established by comparing it 
with another device ; rather, it must be 
approved o n the basis of its own merits. 
State and local rules may not differ, 
except by application to the Secretary of 
HEW; in any case, the local rules mu st be 
more stringe nt than the Federal rule s, as 
may be dictated by local conditions . 
Conclusion 
The intent of Congress in establishing the 
medical devi ce legi slat io n was to improve 
the safety and effectiveness of medical 
devices and to ban those that are unsafe 
and ineffective . Most of the burden of the 
leg islation, currently on the manufacturer, 
vJ ill soon shift to the professional s. Pro-
fess io nal organizations must soo n establish 
safe ty standards for seve ral types of cur-
re ntly used medical devices . Eventually 
the answers to the question of what the 
risk -be nefit rat io is will have to be ex -
plored not on ly by device manufacturers 
but a lso by research and clinical investi -
gators . 
ATS \'·:i ll attempt to keep its membe rshi p 
informed on this important legislat io n 
since it w ill affect all practitioners, scien· 
tific investigators , and o th e rs who are 
invo lved in th e delivery of health care . 
The legislat io n passed w ith minimal con-
cern b·{ manufacturers, pract itioners, or 
professional o rgani zatio ns, and we should 
be prepared as indi viduals and as a profes-
siona l organization to su pport it and he lp 
achieve its goals, rather than fight its 
impl em entation . Those areas where im-
provemen ts are needed should be handl ed 
in a positive, straightforward manner 
w he1·e poss ible, and, where necessary , 
should be challenged in the courts. 
Note : The above review is intended for 
information only . Legal decisions 
should be made only after careful 
evaluation of the documents listed 
below . 
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